Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults, Circulation, 92, 785, 10.1161/01.CIR.92.4.785

Geisterfer-Lowrance, 1990, A molecular basis for familial hypertrophic cardiomyopathy, Cell, 62, 999, 10.1016/0092-8674(90)90274-I

Thierfelder, 1994, Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy, Cell, 77, 701, 10.1016/0092-8674(94)90054-X

Watkins, 1995, Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy, Nat Genet, 11, 434, 10.1038/ng1295-434

Bonne, 1998, Familial hypertrophic cardiomyopathy, Circ Res, 83, 580, 10.1161/01.RES.83.6.580

Marian, 2001, The molecular genetic basis for hypertrophic cardiomyopathy, J Mol Cell Cardiol, 33, 655, 10.1006/jmcc.2001.1340

Moolman, 1997, Sudden death due to troponin T mutations, J Am Coll Cardiol, 29, 549, 10.1016/S0735-1097(96)00530-X

Redwood, 1999, Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy, Cardiovasc Res, 44, 20, 10.1016/S0008-6363(99)00213-8

Sweeney, 1998, Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy, Proc Natl Acad Sci U S A, 95, 14406, 10.1073/pnas.95.24.14406

Spindler, 1998, Diastolic dysfunction and altered energetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy, J Clin Invest, 101, 1775, 10.1172/JCI1940

Lodi, 1999, Deficit of in vivo mitochondrial ATP production in patients with Friedreichs ataxia, Proc Natl Acad Sci U S A, 96, 11492, 10.1073/pnas.96.20.11492

Silvestri, 1997, Maternally inherited cardiomyopathy, Muscle Nerve, 20, 221, 10.1002/(SICI)1097-4598(199702)20:2<221::AID-MUS13>3.0.CO;2-5

Radda, 1986, The use of NMR spectroscopy for the understanding of disease, Science, 233, 640, 10.1126/science.3726553

Watkins, 1992, Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy, N Engl J Med, 326, 1108, 10.1056/NEJM199204233261703

Niimura, 1998, Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802

Crilley, 2000, Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy, J Am Coll Cardiol, 36, 1953, 10.1016/S0735-1097(00)00960-8

Blamire, 1999, Measurement of myocardial pH by saturation transfer in man, Magn Reson Med, 41, 198, 10.1002/(SICI)1522-2594(199901)41:1<198::AID-MRM28>3.0.CO;2-H

Neubauer, 1997, Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy, Circulation, 96, 2190, 10.1161/01.CIR.96.7.2190

Blair, 2001, Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy, J Med Genet, 38, 385, 10.1136/jmg.38.6.385

McKenna, 1997, Experience from clinical genetics in hypertrophic cardiomyopathy, Heart, 77, 130, 10.1136/hrt.77.2.130

Jung, 1998, 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy, Circulation, 97, 2536, 10.1161/01.CIR.97.25.2536

Lamb, 1999, Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism, Circulation, 99, 2261, 10.1161/01.CIR.99.17.2261

Lodi, 2001, Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy, Cardiovasc Res, 52, 111, 10.1016/S0008-6363(01)00357-1

Wallimann, 1992, Intracellular compartmentation, structure, and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands, Biochem J, 281, 21, 10.1042/bj2810021

Kalsi, 1999, Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy, Eur J Clin Invest, 29, 469, 10.1046/j.1365-2362.1999.00468.x

Tian, 2001, Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy, Circulation, 104, 1664, 10.1161/hc4001.097183

Shen, 1999, Progressive loss of myocardial ATP due to a loss of total purines during the development of human heart failure in dogs, Circulation, 100, 2113, 10.1161/01.CIR.100.20.2113

Cuda, 1993, Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy, J Clin Invest, 91, 2861, 10.1172/JCI116530

Tyska, 2000, Single molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopthy, Circ Res, 86, 737, 10.1161/01.RES.86.7.737

Montgomery, 2001, Cardiac troponin T mutations, J Physiol, 536, 583, 10.1111/j.1469-7793.2001.0583c.xd

Seppet, 2001, Functional complexes of mitochondria with Ca, Mg ATPases of myofibrils and sarcoplasmic reticulum in muscle cells, Biochem Biophys Acta, 1504, 379

Blair, 2001, Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy, Hum Mol Genet, 10, 1215, 10.1093/hmg/10.11.1215

Gollob, 2001, Identification of a gene responsible for familial Wolff-Parkinson-White syndrome, N Engl J Med, 344, 1823, 10.1056/NEJM200106143442403

Arad, 2002, Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy, J Clin Invest, 109, 357, 10.1172/JCI0214571

Hardie, 1997, The AMP-activated protein kinase—fuel gauge of the mammalian cell?, Eur J Biochem, 246, 259, 10.1111/j.1432-1033.1997.00259.x